Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution. En savoir plus sur Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution.
Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study. En savoir plus sur Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study.
[Peritoneal dialysis for acute renal failure: Rediscovery of an old modality of renal replacement therapy]. En savoir plus sur [Peritoneal dialysis for acute renal failure: Rediscovery of an old modality of renal replacement therapy].
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century. En savoir plus sur Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century.
Re: Further Evidence Supporting the Accuracy of Quantitative Magnetic Resonance Imaging for Evaluating Iron Load in Dialysis Patients. En savoir plus sur Re: Further Evidence Supporting the Accuracy of Quantitative Magnetic Resonance Imaging for Evaluating Iron Load in Dialysis Patients.
[The use of generics in transplantation: Towards rational and safe solutions!] En savoir plus sur [The use of generics in transplantation: Towards rational and safe solutions!]
[The reality on peritoneal dialysis in France: 40years after]. En savoir plus sur [The reality on peritoneal dialysis in France: 40years after].
When should iron supplementation in dialysis patients be avoided minimized or withdrawn? En savoir plus sur When should iron supplementation in dialysis patients be avoided minimized or withdrawn?
[Impact of comorbidities on hemoglobin stability in patients with chronic kidney insufficiency on hemodialysis treated with CERA in current practice: The MIRIADE study]. En savoir plus sur [Impact of comorbidities on hemoglobin stability in patients with chronic kidney insufficiency on hemodialysis treated with CERA in current practice: The MIRIADE study].
Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations. En savoir plus sur Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations.